+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Respiratory Drugs Market Research Reports

Sleep Apnoea Syndrome - Pipeline Insight, 2025 - Product Thumbnail Image

Sleep Apnoea Syndrome - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 50 Pages
  • Global
From
Chronic Refractory Cough - Pipeline Insight, 2025 - Product Thumbnail Image

Chronic Refractory Cough - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Neonatal Respiratory Distress Syndrome - Pipeline Insight, 2025 - Product Thumbnail Image

Neonatal Respiratory Distress Syndrome - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Pulmonary Alveolar Proteinosis - Pipeline Insight, 2025 - Product Thumbnail Image

Pulmonary Alveolar Proteinosis - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 40 Pages
  • Global
From
From
Alpha-1 Antitrypsin Deficiency- Pipeline Insight, 2025 - Product Thumbnail Image

Alpha-1 Antitrypsin Deficiency- Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Chronic Obstructive Pulmonary Disease - Pipeline Insight, 2025 - Product Thumbnail Image

Chronic Obstructive Pulmonary Disease - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 220 Pages
  • Global
From
Nasal Polyposis - Pipeline Insight, 2025 - Product Thumbnail Image

Nasal Polyposis - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 40 Pages
  • Global
From
Cystic Fibrosis - Pipeline Insight, 2025 - Product Thumbnail Image

Cystic Fibrosis - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 100 Pages
  • Global
From
Asthma - Epidemiology Forecast - 2034 - Product Thumbnail Image

Asthma - Epidemiology Forecast - 2034

  • Report
  • December 2024
  • 152 Pages
  • Global
From
Obstructive Sleep Apnea (OSA) - Epidemiology Forecast - 2034 - Product Thumbnail Image

Obstructive Sleep Apnea (OSA) - Epidemiology Forecast - 2034

  • Report
  • December 2024
  • 75 Pages
  • Global
From
From
From
NUCALA Market Size, Insight, and Forecast to 2032 - Product Thumbnail Image

NUCALA Market Size, Insight, and Forecast to 2032

  • Report
  • December 2024
  • 30 Pages
  • Global
From
XOLAIR Market Size, Insight, and Forecast to 2032 - Product Thumbnail Image

XOLAIR Market Size, Insight, and Forecast to 2032

  • Report
  • December 2024
  • 30 Pages
  • Global
From
TRELEGY ELLIPTA Market Size, Insight, and Forecast to 2032 - Product Thumbnail Image

TRELEGY ELLIPTA Market Size, Insight, and Forecast to 2032

  • Report
  • December 2024
  • 30 Pages
  • Global
From
CINQAIR Market Size, Insight, and Forecast to 2032 - Product Thumbnail Image

CINQAIR Market Size, Insight, and Forecast to 2032

  • Report
  • December 2024
  • 30 Pages
  • Global
From
SPIRIVA RESPIMAT Market Size, Insight, and Forecast to 2032 - Product Thumbnail Image

SPIRIVA RESPIMAT Market Size, Insight, and Forecast to 2032

  • Report
  • December 2024
  • 30 Pages
  • Global
From
ARNUITY ELLIPTA Market Size, Insight, and Forecast to 2032 - Product Thumbnail Image

ARNUITY ELLIPTA Market Size, Insight, and Forecast to 2032

  • Report
  • December 2024
  • 30 Pages
  • Global
From
FASENRA Market Size, Emerging Insight, and Forecast to 2032 - Product Thumbnail Image

FASENRA Market Size, Emerging Insight, and Forecast to 2032

  • Report
  • December 2024
  • 30 Pages
  • Global
From
Loading Indicator

The Respiratory Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs used to treat respiratory diseases. These drugs are used to treat a variety of conditions, including asthma, chronic obstructive pulmonary disease (COPD), and cystic fibrosis. Commonly prescribed respiratory drugs include bronchodilators, corticosteroids, and antibiotics. The Respiratory Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Companies in the market include GlaxoSmithKline, AstraZeneca, Merck & Co., Novartis, and Boehringer Ingelheim. These companies are constantly researching and developing new drugs to treat respiratory diseases, as well as improving existing treatments. Show Less Read more